Rod MacKenzie, Pfizer chief development officer (Chris Ratcliffe/Bloomberg via Getty Images)

Break­ing: Pfiz­er de­vel­op­ment chief Rod MacKen­zie is re­tir­ing af­ter a lengthy ca­reer capped by his­toric suc­cess

Pfiz­er’s clin­i­cal de­vel­op­ment chief and EVP Rod MacKen­zie is re­tir­ing from his post at the phar­ma gi­ant, right on the heels of a his­toric suc­cess.

MacKen­zie was one of the lead­ers in Pfiz­er’s bold push to take an mR­NA vac­cine from their part­ners at BioN­Tech, and was there with CEO Al­bert Bourla and R&D chief Mikael Dol­sten when they took the wraps off the promis­ing piv­otal da­ta that set the stage for a speedy FDA ap­proval fol­low­ing an emer­gency use au­tho­riza­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.